{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T09:22:55Z","timestamp":1788168175120,"version":"build-2803163510"},"reference-count":35,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T00:00:00Z","timestamp":1685664000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003345","name":"Chinese Academy of Meteorological Sciences","doi-asserted-by":"publisher","award":["2020-I2M-C&T-B-052"],"award-info":[{"award-number":["2020-I2M-C&T-B-052"]}],"id":[{"id":"10.13039\/501100003345","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","award":["2020CB012"],"award-info":[{"award-number":["2020CB012"]}],"id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","award":["NCRC2020013"],"award-info":[{"award-number":["NCRC2020013"]}],"id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.isci.2023.107030","type":"journal-article","created":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T14:16:43Z","timestamp":1686147403000},"page":"107030","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Combined effect of D-dimer, hs-CRP, and Lp(a) on 5-year clinical outcomes after percutaneous coronary intervention: A large real-world study in China"],"prefix":"10.1016","volume":"26","author":[{"given":"Jiawen","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kailun","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weixian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubin","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuejin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runlin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinqing","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2023.107030_bib1","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/ije\/dyz099","article-title":"National trends in total cholesterol obscure heterogeneous changes in HDL and non-HDL cholesterol and total-to-HDL cholesterol ratio: a pooled analysis of 458 population-based studies in Asian and Western countries","volume":"49","year":"2020","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.isci.2023.107030_bib2","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/eurheartj\/ehaa099","article-title":"Targeting cardiovascular inflammation: next steps in clinical translation","volume":"42","author":"Lawler","year":"2021","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.isci.2023.107030_bib3","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/clinchem\/hvaa252","article-title":"Residual cardiovascular risk at low LDL: remnants, lipoprotein(a), and inflammation","volume":"67","author":"Hoogeveen","year":"2021","journal-title":"Clin. Chem."},{"key":"10.1016\/j.isci.2023.107030_bib4","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with Canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.isci.2023.107030_bib5","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/S0140-6736(19)31887-2","article-title":"Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial","volume":"394","author":"Bhatt","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.isci.2023.107030_bib6","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s12959-021-00354-y","article-title":"D-dimer for risk stratification and antithrombotic treatment management in acute coronary syndrome patients: asystematic review and metanalysis","volume":"19","author":"Biccir\u00e8","year":"2021","journal-title":"Thromb. J."},{"key":"10.1016\/j.isci.2023.107030_bib7","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1093\/eurheartj\/ehw024","article-title":"Residual inflammatory risk: addressing the obverse side of the atherosclerosis prevention coin","volume":"37","author":"Ridker","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.isci.2023.107030_bib8","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1161\/CIRCULATIONAHA.113.004406","article-title":"Lipoprotein(a) concentrations, rosuvastatin therapy, and residual vascular risk: an analysis from the JUPITER trial (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin)","volume":"129","author":"Khera","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.isci.2023.107030_bib9","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.repc.2020.08.006","article-title":"D-dimers are associated with coronary artery disease severity assessed using Syntax and Syntax II scores in patients with ST elevation myocardial infarction","volume":"39","author":"T\u00fcrko\u011flu","year":"2020","journal-title":"Rev. Port. Cardiol."},{"key":"10.1016\/j.isci.2023.107030_bib10","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jjcc.2019.06.012","article-title":"Impact of high-sensitivity C-reactive protein on coronary artery disease severity and outcomes in patients undergoing percutaneous coronary intervention","volume":"75","author":"Liu","year":"2020","journal-title":"J.\u00a0Cardiol."},{"key":"10.1016\/j.isci.2023.107030_bib11","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.numecd.2019.09.020","article-title":"Lipoprotein(a) levels are associated with coronary severity but not with outcomes in Chinese patients underwent percutaneous coronary intervention","volume":"30","author":"Xu","year":"2020","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"10.1016\/j.isci.2023.107030_bib12","doi-asserted-by":"crossref","DOI":"10.1177\/2040622320904302","article-title":"D-dimer as a thrombus biomarker for predicting 2-year mortality after percutaneous coronary intervention","volume":"11","author":"Zhao","year":"2020","journal-title":"Ther. Adv. Chronic Dis."},{"key":"10.1016\/j.isci.2023.107030_bib13","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/j.jcin.2021.07.042","article-title":"Association of lipoprotein(a) with recurrent ischemic events following percutaneous coronary intervention","volume":"14","author":"Yoon","year":"2021","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.isci.2023.107030_bib14","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1016\/j.jacc.2019.01.077","article-title":"Residual inflammatory risk in patients with low LDL cholesterol levels undergoing percutaneous coronary intervention","volume":"73","author":"Guedeney","year":"2019","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.isci.2023.107030_bib15","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/s12967-022-03448-x","article-title":"Synergistic effect of the commonest residual risk factors, remnant cholesterol, lipoprotein(a), and inflammation, on prognosis of statin-treated patients with chronic coronary syndrome","volume":"20","author":"Liu","year":"2022","journal-title":"J.\u00a0Transl. Med."},{"key":"10.1016\/j.isci.2023.107030_bib16","doi-asserted-by":"crossref","first-page":"11990","DOI":"10.18632\/aging.103365","article-title":"The impact of the cumulative burden of LDL-c and hs-CRP on cardiovascular risk: a prospective, population-based study","volume":"12","author":"Mo","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.isci.2023.107030_bib17","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1161\/CIRCULATIONAHA.117.029901","article-title":"D-dimer predicts long-term cause-specific mortality, cardiovascular events, and cancer in patients with stable coronary heart disease: LIPID study","volume":"138","author":"Simes","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.isci.2023.107030_bib18","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1253\/circj.CJ-19-0624","article-title":"Strategies to overcome residual risk during statins era","volume":"83","author":"Cho","year":"2019","journal-title":"Circ. J."},{"key":"10.1016\/j.isci.2023.107030_bib19","doi-asserted-by":"crossref","first-page":"100432","DOI":"10.1016\/j.cpcardiol.2019.06.004","article-title":"Mechanistic insights to target atherosclerosis residual risk","volume":"46","author":"Alkhalil","year":"2021","journal-title":"Curr. Probl. Cardiol."},{"key":"10.1016\/j.isci.2023.107030_bib20","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/MOL.0000000000000681","article-title":"Lipoprotein(a): is it more, less or equal to LDL as a causal factor for cardiovascular disease and mortality?","volume":"31","author":"Langsted","year":"2020","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.isci.2023.107030_bib21","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/S0140-6736(17)32290-0","article-title":"Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial","volume":"390","author":"Giugliano","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.isci.2023.107030_bib22","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1161\/CIRCULATIONAHA.116.024604","article-title":"Reductions in atherogenic lipids and major cardiovascular events: a pooled analysis of 10 ODYSSEY trials comparing Alirocumab with control","volume":"134","author":"Ray","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.isci.2023.107030_bib23","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3949\/ccjm.60.3.211","article-title":"The role of multiple risk factors in cardiovascular morbidity and mortality","volume":"60","author":"Gifford","year":"1993","journal-title":"Cleve. Clin. J. Med."},{"key":"10.1016\/j.isci.2023.107030_bib24","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0140-6736(02)07813-3","article-title":"Activation markers of coagulation and fibrinolysis in twins: heritability of the prethrombotic state","volume":"359","author":"Ari\u00ebns","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.isci.2023.107030_bib25","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1089\/aid.2016.0134","article-title":"Significant decrease in plasma levels of D-dimer, interleukin-8, and interleukin-12 after a 12-month treatment with rosuvastatin in HIV-infected patients under antiretroviral therapy","volume":"33","author":"Calza","year":"2017","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.isci.2023.107030_bib26","doi-asserted-by":"crossref","first-page":"736466","DOI":"10.3389\/fcvm.2021.736466","article-title":"Similar inflammatory biomarkers reflect different platelet reactivity in percutaneous coronary intervention patients treated with clopidogrel: a large-sample study from China","volume":"8","author":"Li","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.isci.2023.107030_bib27","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1161\/ATVBAHA.111.225508","article-title":"C-reactive protein polarizes human macrophages to an M1 phenotype and inhibits transformation to the M2 phenotype","volume":"31","author":"Devaraj","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.isci.2023.107030_bib28","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0735-1097(97)00237-4","article-title":"Lipoprotein(a) selectively impairs receptor-mediated endothelial vasodilator function of the human coronary circulation","volume":"30","author":"Schachinger","year":"1997","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.isci.2023.107030_bib29","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1194\/jlr.M060210","article-title":"Mechanistic insights into Lp(a)-induced IL-8 expression: a role for oxidized phospholipid modification of apo(a)","volume":"56","author":"Scipione","year":"2015","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.isci.2023.107030_bib30","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/j.jacc.2011.12.033","article-title":"Oxidized phospholipids are present on plasminogen, affect fibrinolysis, and increase following acute myocardial infarction","volume":"59","author":"Leibundgut","year":"2012","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.isci.2023.107030_bib31","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.jacc.2022.05.051","article-title":"Biomarker prediction of complex coronary revascularization procedures in the FOURIER trial","volume":"80","author":"Fagundes","year":"2022","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.isci.2023.107030_bib32","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2147\/CIA.S347168","article-title":"Prognostic value of age-adjusted D-dimer cutoff thresholds in patients with acute coronary syndrome treated by percutaneous coronary intervention","volume":"17","author":"Chen","year":"2022","journal-title":"Clin. Interv. Aging"},{"key":"10.1016\/j.isci.2023.107030_bib33","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/j.ijcard.2013.01.004","article-title":"Prognostic relevance of baseline pro- and anti-inflammatory markers in STEMI: an APEX AMI substudy","volume":"168","author":"van Diepen","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.isci.2023.107030_bib34","doi-asserted-by":"crossref","first-page":"527","DOI":"10.5551\/jat.25551","article-title":"Elevated lipoprotein(a) has incremental prognostic value in type 2 diabetic patients with symptomatic coronary artery disease","volume":"22","author":"Kwon","year":"2015","journal-title":"J.\u00a0Atheroscler. Thromb."},{"key":"10.1016\/j.isci.2023.107030_bib35","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1016\/j.jacc.2018.03.490","article-title":"Inhibition of interleukin-1\u03b2 by Canakinumab and cardiovascular outcomes in patients with chronic kidney disease","volume":"71","author":"Ridker","year":"2018","journal-title":"J.\u00a0Am. Coll. Cardiol."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004223011070?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004223011070?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T09:04:17Z","timestamp":1788167057000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004223011070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S2589004223011070"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2023.107030","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combined effect of D-dimer, hs-CRP, and Lp(a) on 5-year clinical outcomes after percutaneous coronary intervention: A large real-world study in China","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2023.107030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023","name":"copyright","label":"Copyright"}],"article-number":"107030"}}